Tweenvest Stocks

BioPharma Credit PLC (LSE: BPCR)

Financials · Capital Markets · GB

$0.97

-1.43% today · +4.3% 1Y

BioPharma Credit PLC (LSE: BPCR) operates in the Capital Markets industry within the Financials sector. The company is valued at $1.08B and employs 0 people.

Over the last twelve months the share price has gained 4.3%, trading between 0.88 and 1.00.

Tweenvest scores BioPharma Credit PLC across four factors: quality 66/100, value 52/100, growth 36/100, dividend 43/100. Its strongest factor is quality.

BPCR price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$1.08B
Revenue (TTM)
$131.40M
P/E
10.14
EPS
0.10
Dividend yield
8.74%
Beta (5Y)
0.18
52-week high
$1.00
52-week low
$0.88
Avg volume (3M)
—
Shares outstanding
1.12B
Employees
0
Next earnings
—

About BioPharma Credit PLC

As an investment trust, BioPharma Credit PLC primarily allocates its portfolio to debt assets that generate interest. The security for these investments is provided by royalty payments or other cash flows stemming from the sales of officially approved life sciences products. The firm was established in 2016 and maintains its headquarters in Exeter, United Kingdom.

ISIN
GB00BDGKMY29
Founded
2016
Listed since
Mar 27, 2017
Exchange
London Stock Exchange
Currency
USD
CompanyMarket capPriceDay
VanEck ETF Trust - VanEck Agribusiness ETFARCA: MOO$1.12B$80.46-1.08%
IIFL Capital Services LimitedNSEI: IIFLCAPS$1.12BRs343.75-0.54%
Daishin Securities Co.,LtdKOSE: A003540$1.11B₩24,650.00-3.33%
Oakley Capital Investments LimitedLSE: OCI$1.10B£5.06-2.69%
Invesco Exchange-Traded Fund Trust - Invesco High Yield Equity Dividend Achievers ETFNasdaqGM: PEY$1.07B$22.94+0.20%
Monex Group, Inc.TSE: 8698$1.07B¥675.00-1.89%
BlackRock Enhanced Large Cap Core Fund, Inc.NYSE: CII$1.06B$24.33+1.25%
Berliner Effektengesellschaft AGDB: BFV$1.06B€73.00+0.69%

Browse every Capital Markets company →

Figures last refreshed Oct 11, 2026.